Exploring dopa decarboxylase as an ideal biomarker in Parkinson’s disease with focus on regulatory mechanisms, cofactor influences, and metabolic implications
Crossref DOI link: https://doi.org/10.1038/s44385-024-00005-7
Published Online: 2025-01-16
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shebl, Nourhan
Salama, Mohamed
Text and Data Mining valid from 2025-01-16
Version of Record valid from 2025-01-16
Article History
Received: 1 August 2024
Accepted: 29 December 2024
First Online: 16 January 2025
Competing interests
: The authors declare no competing interests.